Swiss multinational company Roche faced global condemnation today from women living with cancer, families of people with cancer, activists, scientists, researchers and health professionals from across the world.
National Black HIV/AIDS Awareness Day (NBHAAD) is being observed this year on Tuesday, February 7. As has been the case for the past several years, the theme for NBHAAD in 2017 is: "I Am My Brother's/Sister's Keeper: FIGHT HIV/AIDS!"
EDGE introduces Dr. Peter Meacher, MD FAAFP AAHIVS, our new resident medical professional who will be writing the Ask the Doc columns. Today's column deals with PrEP resistance and STIs.
Carl Sciortino, Executive Director of AIDS Action Committee, released a statement disapproving of Massachusetts Governor Charlie Baker's recommended funding cuts to their HIV/AIDS budget.
HRC is launching the second year of an intensive, capacity-building fellowship program for young leaders at the front lines of the fight to end the spread and stigma of HIV.
Popular gay hookup site Squirt.org has found chemsex, also known as Party and Play (PNP) or drug-fueled sex, is prevalent with 30 percent of survey respondents admitting that they have engaged in the activity.
The AIDS United Access to Care initiative expanded access to high-quality, life-extending care to over 5,000 people living with HIV, exceeded national viral suppression rates by 27 percent.
The Bill & Melinda Gates Foundation is committing up to $140M in grants and equity with the intent to develop the first once- or twice-yearly anti-HIV prophylactic therapy.
Charlie Sheen is a big cheerleader for CytoDyn's HIV injectable, PRO 140. But the rest of the HIV community would like to see some scientific data on their clinical trails first.
Gilead Sciences, Inc. announced the recipients of its HIV cure grants program, a fund totaling more than $22 million, which will support 12 new HIV cure research projects.